Oscar Health, Inc.
OSCR
$31.76
-$1.25-3.79%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.87B | 4.64B | 2.80B | 2.98B | 2.86B |
| Total Other Revenue | 6.10M | 5.72M | 8.97M | 8.80M | 6.50M |
| Total Revenue | 4.88B | 4.65B | 2.81B | 2.99B | 2.86B |
| Cost of Revenue | 3.79B | 3.23B | 2.62B | 2.59B | 2.55B |
| Gross Profit | 1.09B | 1.42B | 185.16M | 399.65M | 310.97M |
| SG&A Expenses | 691.08M | 706.23M | 511.03M | 521.59M | 534.49M |
| Depreciation & Amortization | 6.06M | 7.02M | 7.88M | 7.31M | 6.97M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.49B | 3.94B | 3.14B | 3.12B | 3.09B |
| Operating Income | 388.64M | 704.09M | -333.75M | -129.25M | -230.48M |
| Income Before Tax | 383.01M | 698.77M | -352.68M | -139.29M | -233.54M |
| Income Tax Expenses | 21.18M | 19.75M | -247.00K | -1.81M | -5.05M |
| Earnings from Continuing Operations | 361.83M | 679.02M | -352.43M | -137.48M | -228.49M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -20.00K | -27.00K | -177.00K | 34.00K | 130.00K |
| Net Income | 361.81M | 679.00M | -352.61M | -137.45M | -228.36M |
| EBIT | 388.64M | 704.09M | -333.75M | -129.25M | -230.48M |
| EBITDA | 394.67M | 711.10M | -325.87M | -121.94M | -223.51M |
| EPS Basic | 1.20 | 2.28 | -1.24 | -0.53 | -0.89 |
| Normalized Basic EPS | 0.79 | 1.46 | -0.78 | -0.34 | -0.57 |
| EPS Diluted | 1.10 | 2.07 | -1.25 | -0.53 | -0.89 |
| Normalized Diluted EPS | 0.72 | 1.32 | -0.78 | -0.34 | -0.57 |
| Average Basic Shares Outstanding | 302.22M | 298.18M | 283.25M | 259.27M | 255.53M |
| Average Diluted Shares Outstanding | 333.43M | 329.75M | 283.25M | 259.27M | 255.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |